Qualigen Therapeutics, Inc. (NASDAQ:QLGN – Get Free Report) saw a significant decrease in short interest during the month of February. As of February 28th, there was short interest totalling 75,300 shares, a decrease of 15.3% from the February 13th total of 88,900 shares. Based on an average daily volume of 49,500 shares, the short-interest ratio is currently 1.5 days. Approximately 11.0% of the shares of the stock are sold short.
Qualigen Therapeutics Stock Performance
Shares of QLGN stock opened at $3.10 on Tuesday. The stock’s fifty day moving average is $3.55 and its 200-day moving average is $5.23. Qualigen Therapeutics has a 52 week low of $2.96 and a 52 week high of $29.44.
Qualigen Therapeutics Company Profile
Recommended Stories
- Five stocks we like better than Qualigen Therapeutics
- How to buy stock: A step-by-step guide for beginners
- Can TikTok Stock Picks Really Make You Rich?
- Canada Bond Market Holiday: How to Invest and Trade
- The “Quality” Rotation: Back to Basics Investing
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Qualigen Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qualigen Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.